CRGC Authors

  • Dall’Era MA, Cress R. Hamilton A.  Response to “Radiation Therapy does not increase survival in addition to standard androgen deprivation therapy for metastatic prostate cancer: an old faded picture?  2018 Jul 5. doi: 10.1002/cncr.31625. link:


  • Mayadev J, Klapheke A, Yashar C, Mell L, I Hsu, Kamrava M, Mundt A, Einck J, Benedict S, Valicenti R, Cress R. Underutilization of brachytherapy and disparities in survival for patients with cervical cancer in California. Gynecol Oncol. 2018 Jul;150(1):73-78. doi: 10.1016/j.ygyno.2018.04.563. link:


  • Babcock BD, Aljehani MA, Jabo B, Choi AH, Morgan JW, Selleck MJ, Luca F, Raskin E, Reeves ME, Garberoglio CA, Lum SS, Senthil M. High-Risk Stage II Colon Cancer: Not All Risks Are Created Equal Ann Surg Oncol. 2018 Jul;25(7):1980-1985. doi: 10.1245/s10434-018-6484-8. link:


  • Jabo B, Lin AC, Aljehani MA, Ji L, Morgan JW, Selleck MJ, Kim HY, Lum SS. Impact of Breast Reconstruction on Time to Definitive Surgical Treatment, Adjuvant Therapy, and Breast Cancer Outcomes. Ann Surg Oncol. 2018 Jul 16. doi: 10.1245/s10434-018-6663-7.   link:


  • Klapheke AK, Yap SA, PanK, Cress RD.  Sociodemographic disparities in chemotherapy treatment and impact on survival among patients with metastatic bladder cancer. In Press.  Urologic Oncology: Seminars and Original Investigations, 36:308. 2018. June      link:


  • Shnorhavorian M, Doody DR, Chen VW, Hamilton AS, Kato I, Cress RD, West M, Wu XC, Keegan THM, Harlan LC, Schwartz SM; AYA HOPE Study Collaborative Group. Knowledge of Clinical Trial Availability and Reasons for Nonparticipation Among Adolescent and Young Adult Cancer Patients: A Population-based Study. Am J Clin Oncol. 2018 Jun;41(6):581-587. doi: 10.1097/COC.0000000000000327.      link:


  • Dall’Era MA, Lo MJ, Chen J, Cress R, Hamilton AS. Nine-Year Prostate Cancer Survival Differences Between Aggressive vs. Conservative Therapy in Men with Advanced and Metastatic Prostate Cancer. Cancer 124:1921-1928. 2018 May link:


  • Dall’Era MA, deVere-White R, Rodriguez D, Cress R. Changing Incidence of Metastatic Prostate Cancer by Race and Age, 1988-2015. Eur Urol Focus. 2018 May 4. pii: S2405-4569(18)30106-8. doi: 10.1016/j.euf.2018.04.016. link:


  • Kimmick GG, Li X, Fleming ST, Sabatino SA, Wilson JF, Lipscomb J, Cress R, Bergom C, Anderson RT, Wu XC; Written on behalf of the Center for Disease Control and Prevention National Program of Cancer Registry Patterns of Care Study Group. Risk of cancer death by comorbidity severity and use of adjuvant chemotherapy among women with locoregional breast cancer. J Geriatr Oncol. 9:214-220. 2018 May   link:


  • Jabo B, Selleck MJ, Morgan JW, Lum SS, Bahjri KA, Aljehani M, Garberoglio CA, Reeves ME, Namm JP, Solomon NL, Luca F, Dyke C, Senthil M. Comparison of perioperative chemotherapy with adjuvant chemoradiotherapy for resectable gastric cancer: findings from a population-based study. J Gastrointest Oncol. 2018 Feb;9(1):35-45. doi: 10.21037/jgo.2017.10.13. link:


  • Aljehani MA, Morgan JW, Guthrie LA, Jabo B, Ramadan M, Bahjri K, Lum SS, Selleck M, Reeves ME, Garberoglio C, Senthil M. Association of Primary Tumor Site With Mortality in Patients Receiving Bevacizumab and Cetuximab for Metastatic Colorectal Cancer. JAMA Surg. 2018 Jan 1;153(1):60-67. doi: 10.1001/jamasurg.2017.3466.      link:


  • Martínez ME, Gomez SL, Tao L, Cress R, Rodriguez D, Unkart J, Schwab R, Nodora JN, Cook L, Komenaka I, Li C. Contribution of clinical and socioeconomic factors to differences in breast cancer subtype and mortality between Hispanic and non-Hispanic white women. Breast Cancer Res Treat. 2017 Nov;166(1):185-193. doi: 10.1007/s10549-017-4389-z      link:


  • Chen Y, Cress RD, Stewart SL, Semrad TJ, Harvey D, Tencredi DJ, Beckett L.  Mediating Effect of Postsurgical Chemotherapy on Presence of Dementia and Survival among Patients 65 and Older with Stage III Colon Cancer. Cancer Epidemiol Biomarkers Prev. 26:1558-1563. 2017 Oct link:


  • McLaughlin RH, Induni M, Cress R. Cancer Registries as a Resource for Linking Bioethics and Environmental Ethics. Am J Bioeth. 2017 Sep;17(9):17-19. doi: 10.1080/15265161.2017.1353167. link:


  • Yuh LM, Lara PN Jr, Wagenaar RM, Evans CP, Dall’era MA, Cress R, Yap SA. A contemporary population-based study of testicular sex cord stromal tumours: Presentation, treatment patterns, and predictors of outcome. Can Urol Assoc J. ;11:E344-E349 2017 Sept link:


  • Denu RA, Hampton JM, Currey A, Anderson RT, Cress RD, Fleming ST, Lipscomb J, Wu XC, Wilson JF, Trentham-Dietz A. Racial and Socioeconomic Disparities Are More Pronounced in Inflammatory Breast Cancer Than Other Breast Cancers. J Cancer Epidemiol. :7574946. 2017. Sept. link:


  • McLaughlin, R.H., Gomez, S.L., Deapen, D., Induni, M. (2017). Human Subjects Protection and Cancer Surveillance Research: Revised Regulations, Expanded Opportunities. Cancer Res. 2017 Jun 15;77(12):3140-3143. doi: 10.1158/0008-5472.CAN-17-0758.2017.           link:


  • Rico A, Pollack LA, Thompson TD, Hsieh MC, Wu XC, Karlitz JJ, West DW, Rainey JM, Chen VW, on behalf of the Enhancement of NPCR for Comparative Effectiveness Research team. KRAS testing and first-line treatment among patients diagnosed with metastatic colorectal cancer using population data from ten National Program of Cancer Registries in the United States. J Cancer Res Ther. 2017 June; 5(2):7-13. DOI: 10.14312/2052-4994.2017-2 link:


  • Jabo B, Morgan JW, Martinez ME, Ghamsary M, Wieduwilt MJ. Sociodemographic disparities in chemotherapy and hematopoietic cell transplantation utilization among adult acute lymphoblastic and acute myeloid leukemia patients. PLoS One. 2017 Apr 6;12(4). link:


  • Yap SA, Yuh LM, Evans CP, Dall’Era MA, Wagenaar RM, Cress R, Lara PN Jr. Evolving patterns of care in the management of stage I non-seminomatous germ cell tumors: data from the California Cancer Registry. World J Urol. 2017 Feb;35(2):277-283. doi: 10.1007/s00345-016-1870-y. link:


  • David EA, Cooke DT, Chen Y, Nijar K, Canter RJ, Cress RD. Does Lymph Node Count Influence Survival in Surgically Resected Non-Small Cell Lung Cancer? Ann Thorac Surg. 2017 Jan;103(1):226-235. doi: 10.1016/j.athoracsur.2016.05.018.      link:


  • Styles T, Wu M, Wilson R, Babcock F, Butterworth D, West DW, Richardson LC. Population-Based Testing and Treatment Characteristics for Chronic Myelogenous Leukemia. J Registry Manag. 2016 Fall;41(3):134-142. PMID: 28121314.



  • David EA, Canter RJ, Chen Y, Cooke DT, Cress RD. Surgical Management of Advanced Non-Small Cell Lung Cancer Is Decreasing But Is Associated With Improved Survival. Ann Thorac Surg. 2016 Oct;102(4):1101-9. doi: 10.1016/j.athoracsur.2016.04.058.      link:


  • Cox C, Chen Y, Cress R, Semrad AM, Semrad T, Gosnell JE, Campbell MJ. Are there disparities in the presentation, treatment and outcomes of patients diagnosed with medullary thyroid cancer?-An analysis of 634 patients from the California Cancer Registry. Gland Surg. 2016 Aug;5(4):398-404. doi: 10.21037/gs.2016.04.02.      link:


  • Cress RD, Chen YS, Morris CR, Chew H, Kizer KW. Underutilization of gene expression profiling for early-stage breast cancer in California. Cancer Causes Control. 2016 Jun;27(6):721-7. doi: 10.1007/s10552-016-0743-4. link:


  • Freedman RA, Kouri EM, West DW, Lii J, Keating NL. Association of Breast Cancer Knowledge With Receipt of Guideline-Recommended Breast Cancer Treatment. J Oncol Pract. 2016 Jun;12(6):e613-25. doi: 10.1200/JOP.2015.008508.      link:


  • Petkov VI, Miller DP, Howlader N, Gliner N, Howe W, Schussler N, Cronin K, Baehner FL, Cress R, Deapen D, Glaser SL, Hernandez BY, Lynch CF, Mueller L, Schwartz AG, Schwartz SM, Stroup A, Sweeney C, Tucker TC, Ward KC, Wiggins C, Wu XC, Penberthy L, Shak S. Breast-cancer-specific mortality in patients treated based on the 21-gene assay: a SEER population-based study. NPJ Breast Cancer. 2016 Jun 8;2:16017. doi: 10.1038/npjbcancer.2016.17. link:


  • Freedman RA, Kouri EM, West DW, Rosenberg S, Partridge AH, Lii J, Keating NL. Higher Stage of Disease Is Associated With Bilateral Mastectomy Among Patients With Breast Cancer: A Population-Based Survey. Clin Breast Cancer. 2016 Apr;16(2):105-12. doi: 10.1016/j.clbc.2015.08.004.       link:


  • Rodriguez DN, Torruellas C, Cress RD. Trends in early-stage hepatocellular carcinoma, California 1988-2010. Cancer Causes Control. 2016 Mar;27(3):325-31. doi: 10.1007/s10552-015-0705-2. link:


  • Denu RA, Hampton JM, Currey A, Anderson RT, Cress RD, Fleming ST, Lipscomb J, Sabatino SA, Wu XC, Wilson JF, Trentham-Dietz A. Influence of patient, physician, and hospital characteristics on the receipt of guideline-concordant care for inflammatory breast cancer. Cancer Epidemiol. 2016 Feb;40:7-14. doi: 10.1016/j.canep.2015.11.003.      link:


  • Clément-Duchêne C, Stock S, Xu X, Chang ET, Gomez SL, West DW, Wakelee HA, Gould MK. Survival among Never-Smokers with Lung Cancer in the Cancer Care Outcomes Research and Surveillance Study. Ann Am Thorac Soc. 2016 Jan;13(1):58-66. doi: 10.1513/AnnalsATS.201504-241OC.                       link: